Shenzhen Hepalink Pharmaceutical Group Co., Ltd. announced the board has resolved not to declare a final dividend for the year ended 31 December 2023 (2022: RMB 1.0 per ten ordinary shares).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.42 CNY | +2.17% | +5.13% | -19.69% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.69% | 1.71B | |
+20.38% | 43.75B | |
+23.94% | 22.06B | |
+13.30% | 14.46B | |
+13.17% | 13.62B | |
+38.36% | 11.61B | |
-9.36% | 6.9B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.64% | 5.32B |
- Stock Market
- Equities
- 002399 Stock
- News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces No Final Dividend for the Year Ended 31 December 2023